UPB Upstream Bio, Inc.
$2.72▼ -1.27%
Healthcare
Other
Volume 56.5K
Avg Volume (10D) 1.39M
Key Metrics & Fundamentals
Market Cap
$148.70M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.68 - 33.68
% vs 50 MA
-47.57%
% vs 200 MA
-72.06%
RSI-14
20.4
MACD Histogram
-0.0600
Beta (1Y vs SPY)
1.16
Free Cash Flow
-$35.62M
Gross Rev
$773,000
Gross Profit
$773,000
EBITDA
-$42.32M
COGS
–
Operating Exp
$43.14M
Operating Income
-$42.37M
EBIT
-$42.37M
Pretax Income
-$39.70M
Net Income
-$39.70M
EPS (Diluted)
-0.72
Price & Volume History
Loading chart…
Recent News
Top Premarket Gainers
MT Newswires · Oct 16, 2026 7:27 AM ET
Top Premarket Gainers
MT Newswires · Sep 8, 2026 7:15 AM ET
Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026
GlobeNewswire · Sep 8, 2026 3:30 AM ET
Upstream Bio on Track to Begin Two Phase 3 Verekitug Trials in Q1 2027
MT Newswires · Sep 1, 2026 7:31 AM ET
Upstream Bio, Inc. (UPB) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 11, 2026 8:35 AM ET
Upstream Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Progress
GlobeNewswire · Aug 11, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See UPB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.